SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001723128-20-000013
Filing Date
2020-08-06
Accepted
2020-08-06 16:22:50
Documents
104
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q amrx-20200630.htm   iXBRL 10-Q 3500776
2 EX-10.1 amnealseveranceplanfin.htm EX-10.1 125724
3 EX-31.1 amrx-2020063010xqexx311.htm EX-31.1 12284
4 EX-31.2 amrx-2020063010xqexx312.htm EX-31.2 12411
5 EX-31.3 amrx-2020063010xqexx313.htm EX-31.3 12470
6 EX-32.1 amrx-2020063010xqexx321.htm EX-32.1 7474
7 EX-32.2 amrx-2020063010xqexx322.htm EX-32.2 7419
8 EX-32.3 amrx-2020063010xqexx323.htm EX-32.3 7501
14 image01.jpg GRAPHIC 12153
  Complete submission text file 0001723128-20-000013.txt   15076951

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amrx-20200630.xsd EX-101.SCH 94129
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amrx-20200630_cal.xml EX-101.CAL 131862
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amrx-20200630_def.xml EX-101.DEF 584630
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amrx-20200630_lab.xml EX-101.LAB 981098
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amrx-20200630_pre.xml EX-101.PRE 685272
15 EXTRACTED XBRL INSTANCE DOCUMENT amrx-20200630_htm.xml XML 3173839
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38485 | Film No.: 201082047
SIC: 2834 Pharmaceutical Preparations